Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210118050067N1Phase 2Completed
Phase 2, single-blind trial of fluorouracil in actinic keratosis (AK) (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Investigator global improvement score. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210118050067N1.